RJFSA
EVGN icon

Raymond James Financial Services Advisors’s Evogene EVGN Stock Holding History

Raymond James Financial Services Advisors’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,008
Closed -$51K – 3331
2021
Q1 		$51K Buy
+1,008
New +$62.4K ﹤0.01% 3100

Other funds holding EVGN

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PP
PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Raymond James Financial Services Advisors's EVGN Position: Q2 2021 in Review

Raymond James Financial Services Advisors sold out of Evogene (EVGN) in Q2 2021, closing a stake of 1,008 shares — an estimated $51K sold.

Raymond James Financial Services Advisors first reported a position in EVGN in Q1 2021 and held it in 1 quarter. The position peaked at $51K in Q1 2021. 42 funds tracked by Wall St. Rank hold EVGN as of Q2 2021.

  • Raymond James Financial Services Advisors reported no remaining Evogene position as of Q2 2021 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 1,008 Evogene shares in Q2 2021, an estimated $51K.
  • Raymond James Financial Services Advisors first reported a position in Evogene in Q1 2021 and held it in 1 quarter.
  • Raymond James Financial Services Advisors's Evogene position peaked at $51K in Q1 2021.
  • 42 funds tracked by Wall St. Rank held Evogene as of Q2 2021.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.